Latest Cancer: Bladder news
Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
posted January 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
Extended Lymphadenectomy Fails to Improve Survival in Bladder Cancer
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Adjuvant Pembrolizumab Improves Survival in Muscle-Invasive Urothelial Cancer
posted September 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Socioeconomic Disparities Impact Immunotherapy Use in Urologic Cancers
posted September 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Thymic Radiation Linked to Worse Outcomes in Patients With NSCLC 
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors 
Cretostimogene Promising for High-Risk, Non-Muscle-Invasive Bladder Cancer 
Omalizumab, Multiallergen OIT Both Viable for Multifood Allergy Treatment Related Articles
Enfortumab Vedotin-Pembrolizumab More Effective for MIBC Than Cisplatin-Gemcitabine 
Perioperative Enfortumab Vedotin + Pembrolizumab Tied to Improved Outcomes With Bladder Cancer 
Meta-Analysis IDs Link Between Type 1 Diabetes and Bladder Cancer Monthly Specialist Briefings
Stay Connected
